Article

Live Broadcast to Explore a Treatment Option for EGFR Exon20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer

In an upcoming live broadcast, Dr. Mark Socinski and Dr. Erminia Massarelli will discuss EGFR Exon20 insertion-positive non-small cell lung cancer and take a deeper look at current guideline-recommended testing. They will also talk about the safety and efficacy of a new option in patients previously treated with platinum-based chemotherapy. Additionally, they will discuss the implications of the data through a live question and answer session.

To obtain expert perspective and learn about how these results may affect your patients and your practice, watch the live broadcast on November 16th at 7PM ET or 9PM ET or November 17th at 12PM ET. To register for the event, visit https://studio.mjhassoc.com/reach/takedaonclivebroadcast.

USO-NON-0332 10/21

Related Videos
Sandip P. Patel, MD
Alissa J. Cooper, MD
Joshua K. Sabari, MD
Eric Kumar Singhi, MD
Eric Kumar Singhi, MD
Karen L. Reckamp, MD, MS
5 KOLs featured in this series
Brendon M. Stiles, MD, discusses the FDA approval of perioperative durvalumab plus chemotherapy in early-stage non–small cell lung cancer.
Cameron James Oswalt MD, fellow, Hematology-Oncology, assistant professor, medicine, Department of Medicine, Duke University School of Medicine
Luis E. Raez, MD, FACP, FCCP